Literature DB >> 6753780

Clinical aerosols. I. Characterization of aerosols and their diagnostic uses.

R V Lourenço, E Cotromanes.   

Abstract

Characterization of an aerosol is of major importance for the understanding of its pathogenic, diagnostic, or therapeutic effect. The parameters necessary for such characterization as well as the methods for obtaining them are reviewed. The factors that determine site of deposition in the human lung are discussed. Further, we have reviewed methods employed to produce aerosols for diagnostic, therapeutic, and clinical research uses. Basic and relatively simple knowledge of aerosol characterization can increase the usefulness of clinical aerosols. Using this knowledge, general principles for aerosol administration are developed. Finally, the application of aerosols in the diagnosis of respiratory diseases is presented; these aerosols include contrast agents, radioactive aerosols, and bronchospastic agents.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6753780

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  8 in total

Review 1.  Pulmonary drug delivery. Part I: physiological factors affecting therapeutic effectiveness of aerosolized medications.

Authors:  N R Labiris; M B Dolovich
Journal:  Br J Clin Pharmacol       Date:  2003-12       Impact factor: 4.335

2.  Nebulization of liposomes. II. The effects of size and modeling of solute release profiles.

Authors:  R W Niven; M Speer; H Schreier
Journal:  Pharm Res       Date:  1991-02       Impact factor: 4.200

3.  The Effect of Active Pharmaceutical Ingredients on Aerosol Electrostatic Charges from Pressurized Metered Dose Inhalers.

Authors:  Yang Chen; Paul M Young; David F Fletcher; Hak Kim Chan; Edward Long; David Lewis; Tanya Church; Daniela Traini
Journal:  Pharm Res       Date:  2015-03-19       Impact factor: 4.200

4.  Factors influencing the size distribution of aerosols from jet nebulisers.

Authors:  M M Clay; D Pavia; S P Newman; S W Clarke
Journal:  Thorax       Date:  1983-10       Impact factor: 9.139

5.  The APE nebuliser--a new delivery system for the alveolar targeting of particulate technetium 99m diethylene triamine penta-acetic acid.

Authors:  R F Miller; P H Jarritt; D Lui; J Kidery; S J Semple; P J Ell
Journal:  Eur J Nucl Med       Date:  1991

6.  Factors affecting total and "respirable" dose delivered by a salbutamol metered dose inhaler.

Authors:  M L Everard; S G Devadason; Q A Summers; P N Le Souëf
Journal:  Thorax       Date:  1995-07       Impact factor: 9.139

Review 7.  Fundamentals of aerosol therapy in critical care.

Authors:  Jayesh Dhanani; John F Fraser; Hak-Kim Chan; Jordi Rello; Jeremy Cohen; Jason A Roberts
Journal:  Crit Care       Date:  2016-10-07       Impact factor: 9.097

Review 8.  Pulmonary route of administration is instrumental in developing therapeutic interventions against respiratory diseases.

Authors:  Xue Jin; Ling Song; Chao-Chao Ma; Yan-Chun Zhang; Shui Yu
Journal:  Saudi Pharm J       Date:  2020-11-04       Impact factor: 4.330

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.